(Q43869797)

English

Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells (English)

1 reference

Europe PubMed Central

27 November 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Ann R Kennedy

1

1 reference

Europe PubMed Central

27 November 2017

X Steven Wan

2

1 reference

Europe PubMed Central

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2002

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

50

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

125-133

1 reference

Europe PubMed Central

27 November 2017

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Chemopreventive agents: protease inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Soy intake and cancer risk: a review of the in vitro and in vivo data

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Human prostate-specific antigen: structural and functional similarity with serine proteases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Molecular mechanisms of TNFalpha cytotoxicity: activation of NF-kappaB and nuclear translocation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Metastatic model for human prostate cancer using orthotopic implantation in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Effect of saponin on the transmucosal passage of beta-lactoglobulin across the proximal small intestine of normal and beta-lactoglobulin-sensitised rats

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

The dilemmas of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10041

21 January 2018

Identifiers

10.1002/PROS.10041

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43869797&oldid=2104051705"